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NMR: Nuclear Magnetic Resonance Spectroscopy 
kDa or Da: kilo Daltons or Daltons. This is equivalent to molecular weight. 
His-Tag: Histidine tag. 6 histidine residues added to a protein to make a charged end. 
Trx: Thioredoxin. A protein meant to fuse with other proteins to encourage expression. 
IPTG: isopropylthiol- -D-galactoside. Induces overexpression of a protein. 
pET: A family of vectors with a T7 promoter region.  
pUC: A family of vectors with a Lac promoter region. 
LB Media: Luria Broth media. Nutritionally rich medium for bacteria. 
M9 Media: rich media for bacterial growth. 
FPLC: Fast Protein Liquid Chromatography 
EDTA: Ethylenediaminetetraacetic acid 
SDS: Sodium Dodecyl Sulfate 
LDAO: Lauryldimethylamine N-oxide. A detergent 
DPC: Diphosphocholine. A detergent 
DDM: n-Dodecyl -D-maltoside. A detergent 
DTT: 1,4- Dithiothreitol. A reducing agent 
DMPC: Dipalmitoylphosphatidylcholine. A Phospholipid. 
MUC1-C+TM: A segment of mucin 1 containing the cytoplasmic tail and the                  
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 NMR spectroscopy has recently become a promising field for protein 
characterization and dynamic studies. As the technology and pulse sequences improve for 
tracking proteins, a greater demand for developing effective purification protocols to 
produce NMR grade protein samples have arisen. This thesis explores two proteins: 
histone H4 tail and Mucin 1; Two very different proteins that require different methods of 
expression and purification to achieve a high enough yield for NMR analysis. H4 is a 
water soluble protein that weighs ~2.7 kDa, and has no extinction coefficient. Since the 
protein is too small for many methods of expression and purification, H4 was attached to 
thioredoxin and a His tag, purified via Ni affinity column, the tags were cleaved with 
thrombin, and the resulting H4 was purified via size exclusion. Mucin 1 is a 
transmembrane protein, and was hard to express within E. coli cells. Adding a 
thioredoxin tag, and switching to C43(DE3) strain of cells encouraged expression of the 
protein. The protein was then suspended in 8M Urea, and purified via size exclusion, and 
thrombin cleavage to remove the thioredoxin. These two different methods of purification 
provide great insight on how to purify many kinds of proteins for NMR analysis, and is 











1.1 General Overview of Growing and Purifying Proteins for NMR Analysis 
 
 While some kinetic studies allow chemists to observe the behavior of proteins 
within their natural environment, many methods –including crystallography and NMR 
spectroscopy- require the protein of interest to be isolated in an ultrapure buffer. Pure 
proteins are rarely abundant enough and selective enough to be extracted from their 
natural eukaryotic cell, so a level of genetic manipulation is required to obtain a sample 
of interest.1 The established method to achieve a high yield of pure protein is as follows: 
clone the genetic sequence for a protein of interest into a vector (to form a plasmid), 
transfer the new plasmid into a prokaryotic cell -commonly a strain if E. Coli-, and 
overexpress the protein within a cell culture (commonly using IPTG to encourage 
overexpression). After the protein is overexpressed, the cell contains relatively very few 
proteins that require extraction from the solution to produce a pure sample of the 
protein.1,2,3 This makes the job far easier to attain a sample for analysis; even in a high 
enough yield for NMR spectroscopic analysis.  
 Depending upon the protein being expressed, methods of purification can vary 
dramatically. Size exclusion and ion exchange columns are the gold standard for 
separating the protein from the rest of the molecular soup produced during expression.1,2,4 
These processes are only effective if the charge or size of a protein varies from common 
proteins expressed by E. Coli.1 In a case where a protein closely resembles other proteins 
within the cell, a histidine tag and thrombin cleavage site can be attached to the protein 
DNA sequence. This gives the protein a highly cationic tail that has a high affinity to a 
nickel column, allowing effective separation.1,5 Thrombin can then be added to cleave 
this site from the tail of the protein, and purified via size exclusion or dialysis.1,6 Once 
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again, these are just a few examples within a library of options available to allow 
purification of a protein.  
 Once a protein is purified, it can be either lyophilized or buffer exchanged into a 
buffer ideal for analysis. In the case of NMR spectroscopy, these buffers are carefully 
prepared to mimic the natural environment of the protein while, at the same time, 
reducing potential signal impairing effects. These buffers allow the protein (ideally) to 
fold properly in its native conformation, and can be analyzed via various two and three 
dimensional pulse sequences.  
 
 
1.2 Gene Vectors and Cell Cultures 
 
 
1.2.1 Common Expression Vectors for Cloning 
 Vectors are a viral or engineered circular plasmid which contain one or many 
insertion sites viable for inserting a DNA sequence.1 A useful vector should contain these 
basic components: an origin region to start transcription of the vector in a bacterial 
organism, a promoter region to encourage a high copy volume of the sequence within the 
vector, a cloning/restriction site(s) for inserting a plasmid DNA sequence of interest, and 
a bacterial resistance marker to purify the future batch of bacterial cells containing the 
vector. There are many other important components comprising a vector, but only the 




Figure 1.1 A Basic Layout of a Vector Plasmid 
 
 
 One of the basic vector sites used for cloning is the pUC family (pUC 8 or pUC 9 
is commonly used). The plasmid is only ~2.8 Kb, contains a Lac promoter, and is 
resistant to ampicillin. The lac promoter is induced by the addition of isopropylthiol- -D-
galactoside (IPTG) during expression. These plasmids are easy to use, and are quite 
cheap to acquire. They are unfortunately, not the most efficient vector for protein 
expression though.8,9 
 The engineered pET family is the usual vector of choice for protein growth within 
bacterial cells. It contains an f1 origin of replication to encourage production even when 
infected with the M13 helper phage. The T7 promoter in pET vectors is much stronger 
than the lac promoter in pUC vectors when induced by IPTG. The cloning sites are highly 
customizable, and can contain a Histidine Tag (e.g. pET 28) or thioredoxin (e.g. pET 32) 
on the N or C-terminal side of your insertion site to make purification easier. The 
resistance marker can change depending upon the class of pET vector as well.10 
The pUC family is cheap and effective if the protein intended for cloning is easy 
to purify from the cellular soup. The pET family is much more expensive, but they are 
very useful for selectively aiding your protein through expression and purification, and is 
amenable to almost any protein available for expression in bacterial cells.  
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1.2.2 Choosing Where to Clone a Protein Sequence into a Vector 
 Many expression vectors contain multiple restriction sites available for cloning 
your DNA sequence into the vector. When using a vector like pET 28, the choice of 
restriction site can dramatically affect the conditions in which your protein is expressed. 




Figure 1.2 an Example of a Cloning Region within a Vector 
 
 
 If the DNA sequence was cloned into the plasmid at Xba I (N-terminus) and Eac I 
(C-terminus), the sequence would only express the protein inserted. If the protein is hard 
to purify alone, a Histidine tag can be attached to the N-terminus of the protein –using 
Xba I and Xho I restriction sites- or to the C-terminus using the Eac I restriction site.1,5,10 
It is important to consider what the protein may need to effectively purify it after 
expression within a bacterial cell.  
 Another point of consideration during cloning is watching the open reading 
frames. Since amino acids are created in sequences of three nucleotides (a codon) at a 
time, it is important to consider where transcription starts, and what codons are being 




Figure 1.3 The Effect of Open Reading Frames on a DNA Sequence 
 
 
 As shown above, depending upon how a sequence is shifted, the DNA sequence 
inserted can result in entirely different protein sequences.1,10 Luckily, the pET vector 
family (as well as a few other expression vectors on the market) accounts for this by 
offering three different vectors (a,b, or c) to allow placement of your protein sequence 
into any reading frame of your choice. Always consider what resulting sequences within 
the coding region of the vector may emerge, and which reading frame the intended 
bacterial colony transcribes in.10 
 The process of cloning a DNA sequence into a vector is mentioned in literature, 
but this paper will not describe the procedure; only the considerations required to plan 
construction of a plasmid. Plasmids used for research within this thesis were constructed 
by external commercial companies. 
 
 
1.2.3 Choosing an E. coli Strain for Bacterial Growth 
 Escherichia coli is the most commonly used bacterial host for protein expression 
due to its ability for rapid growth, simplicity of the cellular structure, and ease of protein 
expression.2,4,5 For most labs, the question of which bacteria should be used for 
expression is not asked; rather the question is, “which strain of E. coli should be used”?  
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 The ‘gold standard’ strain of E. coli for expression is BL21. This cell is equipped 
for lac promoter driven gene expression, which means if the plasmid used contains a pUC 
family vector the protein of interest will be expressed effectively after the addition of 
IPTG. Unfortunately, any plasmid using a T7 promoter is unable to be effectively 
translated in this strain. Furthermore, transmembrane and other toxic proteins would not 
be able to be effectively expressed in BL21.10 
 
 




 BL21(DE3) is a superior variant, since it can express using the lac promoter –in 
the same way as BL21-, and can express with the T7 promoter. These cells are 
engineered to rapidly overexpress the protein of interest -as well as toxic proteins- when 
IPTG is added. This may produce a higher yield of protein, but also it is more important 
to watch cellular growth since it is easy to cause overgrowth and lose the batch.10,11  
 ROSETTA(DE3) cells are a variant of BL21(DE3). The strain is engineered to 
recognize mammalian codons that are rarely found in bacterial cells. This allows certain 
mammalian proteins to be expressed in E. coli without the potential translation errors that 
commonly occur. Beyond this very helpful trait, the cells are almost identical to BL21.10  
 C43(DE3) cells are a variant of BL21(DE3) as well. They are engineered to 
proliferate within a toxic environment. This means proteins can be overexpressed more 
effectively within this cell, and toxic proteins can be effectively expressed in this strain. 
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Furthermore, hydrophobic or transmembrane proteins can be expressed in C43 with a 
relatively high yield. This strain of E. coli is considered to be one of the best strains for 




1.2.4 Expressing a Protein in Bacterial Cells 
 Once a plasmid is prepared and appropriate bacterial cells are chosen, expression 
of the intended protein can commence. To accomplish this, the plasmid must be first 
shuttled into the bacterial cell. A small volume –usually 1 or 2 μL- of the plasmid is 
chilled with a small volume –usually 10 μL- of bacterial cells within a suspension of 
Luria broth (LB) media. The solution is then heat shocked to encourage the bacterial cells 









 Once the bacteria have enveloped the plasmid, the solution is spread over an 
antibiotic LB agar plate. The antibiotic should match the antibiotic resistance of the 
plasmid introduced. This should encourage colony growth of cells exclusively carrying 
the plasmid. A colony can then be transferred to a vial containing a few milliliters of LB 
media, and incubated to encourage bacterial growth.1,11,12  
 The culture can then be transferred to a half liter or liter of purified M9 media 
containing antibiotic. The media can contain isotopically labeled N15 ammonium salts or 
C13 glucose if desired for future research. The container should be either twice as large as 
the volume of the solution, or equipped with an aerator to ensure sufficient oxygen is 
present for cell growth. The solution is then incubated and agitated to encourage bacterial 
growth. As the optical density (A600) of the solution reaches 0.7, IPTG is added to induce 
overexpression of the protein. After a period of incubation, the cells will be ready for 
purification. This incubation time may vary depending upon the cells used (see chapter 
1.2.3), and the plasmid constructed.1,11,12  
 
 
1.3 Purifying a Cell Culture 
 
 
1.3.1 Purification of a Water Soluble Protein 
 Hydrophilic proteins are relatively easy to purify, since they dissolve in most 
buffers safe for FPLC, and retain their native structural conformation without special 
detergents or lipids. The first step is to spin down the cell culture, and collect the pellet. 
The bacterial cells can then be re-suspended in a buffer viable for subsequent purification 
steps.1,12  
 Buffers may vary depending upon the protein of interest and intended pH of the 
solution. For physiological pH (~7.4) 50 mM Tris-HCl is a useful buffer. Adding salt can 
mimic the environment of a cell, and adding a small concentration of 
Ethylenediaminetetraacetic acid (EDTA) can help prevent aggregation or protein 
fragmentation during purification.1,12  
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 Once a buffer is chosen, and the cells are re-suspended in it, the solution is ready 
for cell lysis. There are two common methods used for cellular lysis: First, using a French 
press and exert over 1000 PSI of force on the solution. Second, sonicate the solution with 
rapid, high frequency pulses. This ensures the proteins within the cell are extracted and 
suspended in the buffer. The solution is then re-centrifuged, and the supernatant -
containing water soluble, cellular proteins- is collected.1,11,12  
 Once the solution is collected, the proteins can be separated in a variety of ways. 
If the protein is a size quite different from other naturally occurring proteins within E. 
coli, the sample would be run through a gel filtration (size exclusion) column. At a slow 
flow rate, the larger proteins elute at an earlier rate than the smaller proteins, and elution 
fractions are collected over time. These fractions should contain a purified sample ready 
for further study.1,11,12,13 
 Alternatively, if a sample cannot be effectively separated via size, the protein can 
be separated by charge. Either the protein may naturally have a high charge, or a histidine 
tag is attached to the end of itself. When introduced into the column, a buffer (buffer A) 
is washed through the column allowing the charged protein to stick to the resin, and all 
other proteins elute through the column. After the column is washed with at least 3 or 4 
column volumes, a second buffer (buffer B) is introduced into the column as a gradient 
between buffers A and B. Buffer B should contain a chemical with a high affinity to the 
resin (such as Imidazole for a Ni affinity column) that displaces the protein of interest, 




Figure 1.5 Diagram of Two Common Separation Columns 
 
 
 If a His tag is attached to a protein sample, it is imperative to remove the tag. 
Usually a His tag is followed by a thrombin cleavage site.  After a sample is separated via 
Ni affinity column, the eluted fractions can be prepared for cleavage. The sample must 
first be buffer exchanged to a low salt buffer that doesn’t contain imidazole –since 
imidazole inhibits activity of thrombin-. Furthermore, if the sample buffer contains 
detergents or lipids (See section 1.3.2), thrombin activity will also be inhibited. Buffer 
exchange can be accomplished via dialysis or filter centrifugation.1,12,13 
 Once the protein is in an imidazole free buffer, 3-10 units of thrombin is added 
per 1mg of protein at room temperature overnight. This value can vary, and is highly 
dependent on temperature, time, and the protein being used. Much of literature suggests 
testing multiple conditions for optimal thrombin cleavage, since too much cleavage can 
result in degradation of the protein of interest. 14 
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 Once the protein is cleaved, the sample will need to be re-purified. This can be 
accomplished via dialysis (if the protein is large enough for cellulose membranes), or via 
size exclusion. Even if the protein doesn’t require cleavage, it may require multiple 
purification steps to attain an NMR grade sample. It is important to balance the iterations 
of purification with the half-life of the protein. If the concentration halves every 6 hours 
and the procedure calls for 3 column purifications, there may not be a sample after 
purification ends. Given any of the above methods, once a sample is purified, it is ready 
for buffer exchange to a concentrated sample ideal for NMR analysis.  
 
1.3.2 Purification of a Hydrophobic Protein 
 Hydrophobic or amphiphilic (partially hydrophobic) proteins are hard to purify 
since they usually degrade fast in a non-native environment, and require detergents or 
lipids to encapsulate the protein through purification. The first step for purification is 
deciding which detergent or lipid would be best for suspending the protein of interest in 
the buffer. Table 1.2 below describes a few of the common dissolving chemicals used for 
suspending insoluble proteins.11,13 
 There are many factors to consider when choosing the right detergent/chemical 
for suspending a protein: Does the protein retain its native conformation? If it doesn’t it 
may be much easier for the protein to degrade or become cleaved by other enzymes in 
solution. Does it work well with the method of purification intended? Urea is highly 
corrosive, and some detergent micelles may be too large for some filtration methods. 
Does the protein require a mild or harsh detergent? Mild detergents aren’t as positively 
charged and have long hydrocarbon tails. They are harder to suspend some proteins, but 
are gentle on easily degradable/reactive proteins. Harsh detergents are the opposite. How 
easy is it to exchange the protein to another buffer? Some detergents like SDS adhere to 
proteins quite strongly, and require buffer exchange to urea, then to another detergent; 
Valuable time would be spent exchanging the protein to a buffer viable for NMR while 





Table 1.2 Common Dissolving Chemicals for Suspending Insoluble Proteins 
 
 
   
 Once a detergent is chosen, the buffer can be prepared in a similar manner as 
described in section 1.3.1. Tris-HCl is a useful physiological buffer, and salt and EDTA 
can be useful for any buffer. On top of the basic solution, the intended detergent should 
be added well above the critical micelle concentration to ensure micelles form to trap the 
protein of interest. If the protein of interest has a high propensity to aggregate, turning the 




Figure 1.6 Process of Suspending a Protein in Detergent 
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 Purification begins in a similar manner as described in section 1.3.1. The bacterial 
cells are centrifuged down to a pellet, and the pellet is re-dissolved in the premade buffer 
containing detergent. The cells are then lysed, and the proteins should dynamically re-
suspend in a detergent micelle. Then the solution is re-centrifuged to discard the inclusion 
bodies. The supernatant is then prepared for purification. Ion and size exclusion columns 
are useful for purifying, although it is important to consider the effects of the detergent on 
the machines and columns being used (see table 1.2 and section 1.3.1 for more detail). 
Once purified, the samples are ready to be prepped for NMR analysis.15,16,17 
 
 
1.3.3 Preparing a Sample for NMR Analysis 
 For water soluble proteins, the NMR buffer is ideal when there is a low salt 
concentration. Citrate, Tris-d11, or Na/K phosphate buffers are useful for NMR analysis 
(using 95% deuterated water as a solute). Buffers should be prepped for physiological pH 
as well as below pH 6, since NH exchange is slowed. 5mM DTT or 10mM CHAPS are 
useful to prevent dimer/oligomerization of the protein, and 5mM EDTA can be useful to 
prevent denaturation of the protein. It is generally advisable to first examine literature to 
mimic a buffer previously used for the protein of interest (or a similar protein), or modify 
the buffer based on literature.15,16 
 If the sample is being prepped at a future time, the sample can be buffer 
exchanged to water via dialysis or filter centrifugation, and then lyophilized. The protein 
can then be directly rehydrated in an NMR buffer of choice at the proper volume. 
Alternatively, the NMR buffer can be added to the purified sample, and buffer exchanged 
via filter centrifugation, then concentrated to the proper volume.  
 For Hydrophobic proteins, the same methodology can be followed. Detergents 
such as DDM (n-Dodecyl  -D-maltoside) and DPC (diphosphocholine) can remain in the 
NMR buffer since it is ideal for characterizing proteins in their native conformation.15,16 
Others –like urea- require buffer exchange to another detergent for NMR analysis. In 
many cases these detergent micelles can mimic a native lipid environment, but for certain 
proteins, detergent is not sufficient to encourage native behavior or conformational 
14 
 
structure. For these class of proteins, nanodiscs are ideal for mimicking the cell wall 
while being small enough for NMR characterization.18,19  
 Nanodiscs are lipids (such as DMPC) encapsulated by a flexible  -helical 
amphiphilic protein (commonly MSP). The size of the disc is determined by the size of 
the amphiphilic protein, and the formation of a nanodisc is spontaneous and very 
favorable. To form the discs, a solution is prepared with MSP (or another protein) and 
lipids at an 80:1 lipid to amphiphilic protein ratio (suggested ratios may differ depending 
upon the protein). Nanodiscs spontaneously form. The Protein solution of interest is 
added to the nanodiscs, and agitated. The final mixture can be dialyzed in water to elute 




Figure 1.7 Diagram of Nanodisc Formation and Protein Encapsulation 
 
 
 Nanodiscs are incredibly useful since they generally increase the half-life of a 
protein dramatically, and even encourage transmembrane proteins to behave normally; 
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As if it were embedded in its native membrane within the cell. This attributes are ideal 
for 3D NMR experiments that may take days or even weeks to run.18,19,21  
 
 
1.4 Advantages and Disadvantages to Studying Proteins in This Manner 
 Concerning the use of bacteria as a medium for expression: When a eukaryotic 
protein is able to be expressed in E. coli, the yield is far higher than being able to extract 
it from its naturally occurring source, and with greater ease. Unfortunately, not all 
eukaryotic proteins can be effectively expressed in this manner. Some bacteria may 
disassemble proteins during transcription, others are simply unable to transcribe the 
protein, and some transcribe it improperly and the protein cannot fold in its native 
conformation.11 There are currently cell-free methods of protein production that use the 
same molecular machinery for transcription, but floating in a solution instead of within a 
cell. This produces a pure product right away (which is always beneficial), but this 
method is relatively new, and has its own issues.20 
 Preparing cell cultures for NMR analysis is quite challenging, relative to 
preparing a protein for mass spectroscopy, x-ray crystallography, isothermal calorimetry 
studies, or other methods of protein characterization. This is because NMR requires a 
relatively high concentration of protein, and a very pure sample of that protein. For some 
proteins that have a low half-life, this can prove to be more than challenging. Why study 
via NMR when many structural, binding, and dynamic studies can be performed through 
the means of various experiments?16,21 
 The reason is NMR is able to do the work of many studies, and obtain more 
relevant data. NMR is able to not only characterize the structure of the protein, but it is 
able to do so in its native conformation, and see its dynamic structure (even for 
disordered proteins). NMR can perform binding studies, and see how the structure 
changes as a protein binds. The process of obtaining a sample for NMR analysis may be 
challenging, but information obtained is much faster and more illuminating once the 




1.4 Proteins Examined Within Thesis 
 
 
1.5.1 Histone H4 Tail 
 The Histone H4 Tail is one of 5 proteins that comprise the structure of chromatin 
in eukaryotic cells. Chromatin helps regulate DNA replication, and packages DNA after 
replication. It also helps reinforce and protect the DNA during mitosis. For better or 
worse, the H4 tail is easily subject to acetylation and methylation, which can affect DNA 
replication -and ultimately alter gene expression- because it interferes with inter-
nucleosomal packaging. The actual process of these interactions are not fully known, and 
is subject to much study.22 
 The H4 Tail is useful for NMR in two ways: first, further studies are needed to 
fully understand its interaction with other proteins/chemicals and its ultimate effect on 
DNA replication. NMR would be useful for observing some of these interactions. 
Second, H4 is a small disordered protein that is hard to characterize given modern pulse 
sequences. It is a great protein for testing certain new pulse sequences, and furthering the 
scientific field of NMR as a whole. 
 
 
1.5.2 Mucin 1 
 Mucin 1 is a transmembrane protein commonly located in the apical border of a 
mucosal cell. The protein contains a sea urchin sperm protein-enterokinase-agrin (SEA) 
domain that undergoes autocleavage, producing two subunits. Under cellular stress the N-
terminal subunit of MUC1 is released outside the cell to form a physical barrier around 
the cell surface, while the C-terminal subunit remains partially embedded in the cell wall 
and extends into the cytoplasm. When this occurs across a series of cells on the surface of 
tissue, a thin mucus layer forms (e.g. within the colon, intestines, and breasts).23  
The cytoplasmic portion of MUC1 is able to interact with many transcription 
factors, epidermal growth factor receptors (EGFRs), tyrosine kinases, and other signaling 
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proteins throughout the cell that promotes cellular resistance and transcription of 
itself.23,24,25 It is believed MUC1 usually remains a homodimer when clustered in low 
concentration around the apical border of the cell, but when polarity of the cell is 
compromised, MUC1-C disperses across the entire cell surface, and is able to interact 
with the aforementioned proteins.23,25  
Polarity of the cell is affected when the cell undergoes extracellular stress, or 
when the cell becomes cancerous. In the prior condition, MUC1-C will temporarily 
encourage cellular signaling to bolster cellular defense, and then retreat back to the apical 
border as cellular stress is reduced. It is theorized that in cancerous cells, MUC1-C will 
spread across the cell long enough to proliferate, and bind with tyrosine kinases and 
ERBB2 to further disrupt the polarity of the cell.23,25 Once this occurs, MUC1-C will 
interact with JAK1 and STAT3 to promote transcription of itself, and ultimately establish 
an autoinductive loop that will encourage over expression of MUC1 and STAT3. As the 
concentration of MUC1 increases, MUC1-C domain will oligomerize and spill into the 
cytoplasm and further dimerize with Importin-  to cross the nuclear barrier, or with 
HSP70 and HSP90 to enter the mitochondria, and promote expression of genes involved 
in proliferation and survival of the cell.23 This cascade of events leads to an inhibition of 
apoptosis, increased defense of the cellular membrane, and accelerated cell 
growth/division; many of the destructive hallmark signs of cancer. Although this 
proposed process is currently debated, it is known mucin 1 has a direct influence on the 
proliferation of cancerous cells.23,24,25 
It is believed MUC1-C dimerizes with many of these signaling proteins by 
forming a disulfide bond within its CQC motif found in the cytoplasmic tail of the 
protein. By blocking the CQC motif, or mutating it to AQA, MUC1-C loses its activity 
almost entirely, and renders a cancerous cell non-tumerogenic; Sometimes killing the cell 
entirely.23,24,25 Surprisingly, MUC1 does not bind to STAT3 with its CQC motif, but the 
inhibition of CQC with a cell penetrating peptide like GO-201 disrupted MUC1-STAT3 
interaction completely; Indicating the CQC motif was still important in maintaining 
stability of the complex.24  
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Beyond simply tracking MUC1-C signaling, and noting the significance of the 
protein's inhibition within the cell, animal and human trials have shown CQC inhibiting 
peptides - such as GO-201 - actually cause recession of mucosal cancer within a 
biological system.23,24 This makes MUC1-C a very significant protein, and one that 
should be studied thoroughly to devise the most effective means of inhibition for cancer 
treatment.  
Unfortunately, besides the alpha helical transmembrane (~23 amino acids long) 
segment, the cytoplasmic subunit is intrinsically disordered. Because of the disordered 
nature of MUC1-C, it is hard to predict its dynamic structure, and ultimately, its method 
of interaction with important molecules of interest.26 Furthermore, characterizing its 
structure via crystallography or other solid state methods alone will not provide any 
useful data, since it is improper to assume the packing structure of an intrinsically 
disordered protein is in any way indicative of its dynamic structure in solution. Therefore, 
Solution NMR is necessary to characterize the structure of MUC1-C alone, as well as 
characterizing it as a homodimer and heterodimer with many cytoplasmic proteins such 




The objective of this research was to develop and optimize protocols for 
expressing and purifying the histone H4 tail and MUC1. For MUC1, once the C subunit 
was characterized, focus was directed to creating a plasmid to express the transmembrane 
domain –as well as the C subunit- of MUC1. Once accomplished, plans were made to 
purify the protein and prepare samples containing DDM detergent and nanodiscs 
(separately) for NMR analysis and characterization.  
 NMR studies have been performed on both proteins studied within this thesis, but 
the assignments will not be mentioned in detail since other members of Dr. Skrynnikov’s 
lab completed this task. The work embodied here focuses almost exclusively on 












2.1 Preparing Histone H4 Tail for NMR Analysis 
 
 
2.1.1 Expressing and Purifying Histone H4 Tail 
 The plasmid for the histone H4 tail was developed by Adam Groves of Dr. 
Skrynnikov’s lab, and created commercially by GenScript. The genetic sequence was 
cloned into a pET-32b vector containing ampicillin resistance. Thioredoxin and a 
histidine tag was attached to the N-terminal end of the protein. BL-21(DE3) 
ultracompetent cells were used as the bacterial medium for protein expression. The 
following is the optimized purification protocol developed for histone H4 tail. 
 1μL of 0.01mg/mL Plasmid was added to 10μL of BL-21(DE3) cells, and allowed 
to mix for 30 minutes on ice. The sample was then heat shocked at 37º C for 30 seconds, 
then cooled on ice for 2 minutes. 900μL of LB media was added to the mixture, and 
incubated for a half hour at 37º C. The cells were then spun down, and 200 μL were 
transferred to an ampicillin resistant plate.  
 After 16 hours the plates were checked, and a colony was chosen for cell cultures. 
The colony was transferred to two vials containing ~7mL LB media and incubated for 16 
hours at 33º C while agitated at 250 rpm. After that time, 0.5L of M9 media was prepared 
at pH 7.4 containing ampicillin in a 2 liter flask and autoclaved. For initial runs to test 
expression, nothing was isotopically labeled. After expression conditions were optimized, 
N15 ammonium salts and C13 glucose were added to the media.  
 5 mL of the LB media cultures were transferred to the M9 media, and incubated at 
37º C while agitated at 300rpm. When the optical density (at 600 nm) reached ~0.7 
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(roughly 8 hours), 1mL of IPTG and more ampicillin was added to induce overexpression 
of our protein. The cells were ready for purification after about 15 hours.  
 The cellular media was centrifuged down at 8000 rpm for 15 minutes at 4ºC. The 
supernatant was discarded, and the pellet was suspended in Buffer A (50 mM Tris-HCl, 
200 mM NaCl, and 10 mM EDTA). The cells were lysed via French press at 1100 psi 
three times. The final product was centrifuged again at 28000 rpm for 30 minutes at 4º C, 
and the supernatant was collected.  
 The solution was prepared for FPLC by passing through a .22 micron filter. Since 
H4 contained a His tag, an Atka Start FPLC was equipped with a 10mL Ni affinity 
column, and equilibrated with buffer A. The sample was injected into the FPLC at 
2mL/min, and washed with buffer A for 5 column volumes. A gradient between buffer A 
and buffer B (50 mM Tris-HCl, 200 mM NaCl, 10 mM EDTA, and 250 mM imidazole) 
was created, and fractions of the elution were collected. An example of the elution results 
are shown in figure 2.1 below.  
 As one can see, there was sufficient separation displayed on the chromatogram as 
imidazole (buffer B) saturated the column. The strong elution peak was confirmed to 
contain the Trx+H4+His-tag fusion protein via SDS PAGE gels (not shown). The peak 
fractions were collected, concentrated to 5 mL by centrifuging the sample at 1300 rpm 
using an amicon 5 kDa MW cut off filter tube.  
1 mg of thrombin was added to the solution at 37º C for 4 hours to cleave the His-
tag and thioredoxin (Trx). Normally a concentration of the protein –and the related 
amount of thrombin needed- would be determined using UV/VIS, but H4 has an 
extinction coefficient that is approximately zero. Therefore it is quite hard to determine a 
concentration. After a series of thrombin cleavage tests, the aforementioned method of 





Figure 2.1 Absorbance Reading of H4 Tail Eluting from the Ni Column 
 
  
 Once the thrombin completed cleaving the protein, the sample was filtered 
through a .22 filter, and prepared for size exclusion. An Atka Start FPLC was equipped 
with a 120 mL HiLoad 16/60 superdex 75 prep grade size exclusion column, and the 
system was equilibrated with nanopure water. The sample was injected at a flow rate of 
0.5 mL/min, and 5mL factions were collected. After extensive sets of SDS PAGE gels, 
H4 was discovered purified (see figure 2.2).  
 The pure histone H4 tail was then lyophilized, and ~13mg samples were obtained 
per preparation. H4 was confirmed using mass spectrometry. The theoretical molecular 
weight of H4 with an N15 label should be 2693.4 Da, and experimental results (see figure 
2.3) show the molecular weight of the protein is 2693 Da. Further confirmation was made 





Figure 2.2 SDS PAGE Gel Results of A.) Thrombin Cleavage of H4 and B.) Size 





Figure 2.3 Mass Spectrometry Results for Purified H4 Tail 
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2.1.2 Preparing an NMR Sample of Histone H4 Tail  
 
Since the H4 tail was lyophilized, and the protein is water soluble, preparing the 
sample for NMR analysis is relatively simple. A 50 mM citrate buffer containing 95% 
deuterated water, 5 mM DTT, and 5 mM EDTA was freshly prepared. 250 μL of buffer 
dissolved 5mg of H4 tail, and the sample was transferred to a shigemi tube for analysis. 
Further NMR experiments were conducted on the sample by Adam Groves and Oleg 
Omikhail in Dr. Nikolai Skrynnikov’s lab.  
 
 
2.2 Preparing Mucin 1 for NMR Analysis 
 
2.2.1 Developing a Mucin 1 C+TM Subunit Plasmid 
 
 Since it is known the mucin 1 C-subunit contains the CQC motif –which is 
known to dimerize with many cytoplasmic proteins- it is important to focus expression on 
a portion of Mucin 1 containing the cytoplasmic tail. Many of these interactions occur 
near the cell wall, so to fully attain proper folding and behavior of the C-subunit, the 




Figure 2.4 A General Map of Mucin 1 Sequence 
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 The cytoplasmic portion of Mucin 1 (MUC1) is displayed in figure 2.4. On top of 
that genetic sequence, the transmembrane element (literature indicates the  -helix is ~23 
amino acids) and an additional 9 amino acids (to ensure proper  -helical folding) on the 
N-terminal end were added to the intended protein sequence for expression. This 




 Where the red region indicates the transmembrane segment, and the yellow region 
highlights the CQC motif. pET-28a was chosen as the vector, and the following 
restriction sites were chosen for inserting the MUC1-C+TM (cytoplasmic and 
transmembrane segment) sequence: Nde1 and Xho1. The intention behind this decision 




Figure 2.5 pET-28a Cloning Region and Intended Insertion Sites 
 
 This insertion allowed a His-tag and a thrombin cleavage site to attach to the N-
terminal end of the protein. Adding a stop codon at the end of the sequence would 
prevent the addition of another His-tag at the C-terminal end. These specifications were 
given to GenScript, and their company constructed a plasmid for research. Once the 
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plasmid was obtained, and sequenced (to ensure the plasmid contains what was asked), it 
was prepped for expression of MUC1.  
 
 
2.2.2 Expressing Mucin 1 C+TM 
 
 The plasmid was initially expressed in Bl-21(DE3) ultracompetent cells. 1μL of a 
0.001 mg/mL solution of plasmid was added to 10μL of Bl-21(DE3) cells, and allowed to 
chill on ice for 30 mins. The sample was then heat shocked at 37º C for 30 seconds, then 
cooled on ice for 2 minutes. 900μL of LB media was added to the mixture, and incubated 
for a half hour at 37º C. The cells were then spun down, and 200 μL were transferred to 
an ampicillin resistant plate. The rest of the expression protocol is exactly as described 
for the histone H4 tail in section 2.1.1.  
 After the media had been spun down, the pellet was re-suspended in a detergent 
buffer, since MUC1-C+TM is partially hydrophobic. The buffer contained 50mM Tris-
HCl, 0.1M n-Dodecyl  -D-maltoside (DDM detergent), 200mM NaCl, and 5 mM EDTA. 
The cells were lysed via French press at 1100 psi in triplicate, then centrifuged down 
again. The supernatant was then injected into an Atka start FPLC with a 120 mL HiLoad 
16/60 superdex 75 prep grade size exclusion column attached. The column was 
equilibrated with the same suspending buffer, and the sample was run through at 0.5 












Figure 2.7 SDS PAGE gel of Size Exclusion Fractions Collected 
 
 
 These results show there was little to no significant expression of MUC1-C+TM. 
No band before or after lysis shows a strong band of protein around the molecular weight 
of Mucin (~26 kDa including the His-tag and thrombin cleavage site), and all elution 
absorbance peaks are relatively weak. This questions if MUC1-C+TM can really be 
expressed under these conditions. 
 Assuming MUC1-C crashed out of solution (DDM detergent may have been too 
weak), a new buffer was prepared containing 12M urea (as well as 50mM Tris-HCl, 
200mM NaCl, and 5 mM EDTA) to encourage dissolution of all possible proteins within 
E. Coli. Two batches of cellular media were grown; one batch induced with IPTG 
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(mimicking the previous protocol) and one without IPTG induction. Before lysis, the both 
batches were dissolved in the urea buffer. When the solutions were spun down to remove 
any inclusion bodies, there was no pellet formation, indicating the entire cell had 
dissolved in solution. An SDS gel was run on the solutions (4x diluted to prevent urea 
interfering with SDS results). The results are noted in figure 2.8 below: 
 
 
Figure 2.8 Mucin1 IPTG (+/-) SDS PAGE Results 
 
 
 Figure 2.8 shows the results for the two batches - IPTG (noted as +) and no IPTG 
(noted as -) - in various dilutions from their native concentration (described in percents). 
This IPTG +/- test revealed there is no expression of MUC1-C in the cell whatsoever. 
Both IPTG induced and non-induced bands are exactly the same, where if there was any 
expression at all, there would be a presence of a new strong band in the IPTG+ columns. 
 Since the protein cannot be expressed using BL21 cells, the same tests were 
conducted using ROSETTA(DE3) and C43(DE3) cells. During these experiments, 
careful attention was paid to ensuring optimal expression conditions. As seen in Figure 
2.9 below, both strains failed to produce any Mucin1 protein. Since C43(DE3) is the most 
effective strain of E. coli in its ability to express transmembrane proteins, it was 






Figure 2.9 SDS PAGE results of A.) ROSETTA cells and B.) C43(DE3) Cells tested for 




2.2.3 Revising the Mucin 1 Plasmid and Attempting Expression 
 
 A fellow colleague from St. Petersburg Russia, Yulia Pivovarova, suggested 
changing the vector used for expression. If the same protein sequence were used in a 
pET-32b vector, mucin1 could be fused to a thioredoxin protein found within the cloning 
region of the vector. Thioredoxin (Trx) is known to –when fused with another protein- 
encourage expression of normally inexpressible proteins.17 The decision was made to 
create another plasmid using this concept, and Trx was added to the N-terminus of the 
protein along with a thrombin cleavage site linking the two.  
 The plasmid was expressed in C43(DE3) cells using the same procedure 
discussed in section 2.1.1. The sample was then centrifuged, the pellet was collected, and 
re-suspended in an 8M Urea buffer. The cells were lysed, and re-centrifuged. After 30 
minutes of centrifugation at 18000 rpm, no pellet formed; indicating all proteins were 
dissolved in the urea buffer. The same procedure was conducted without the addition of 




Figure 2.10 IPTG +/- Results for Trx-Mucin1 protein in 8M Urea 
 
 
 The results of the IPTG +/- test indicate absolute expression of the Trx-MUC1 
fusion protein. The addition of thioredoxin actually encouraged expression of MUC1-
C+TM, a normally inexpressible protein! Since High levels of urea can dissolve almost 
anything, it is important to test various detergents to see what the mucin construct can 
suspend in for future purifications and preparations for NMR study. Five detergents were 
added to the following buffer separately: 50mM Tris-HCl, 200 mM NaCl, 10 mM 2-
mercaptoethanol, and 2mM EDTA. The five detergents were as follows: 8M Urea, 4% 
Triton X-100, 1% SDS, 2mM DPC, and 1.5% DDM. After Lysis, each cell culture 
suspended in the different detergent buffers were collected for an SDS-PAGE gel for 
comparison. The results are shown below. As a note, the DPC results were obtained on a 
separate gel, so the bands will not ideally align with the other bands. This does not affect 




Figure 2.11 SDS-PAGE of Various Detergents Suspending Trx-MUC1 Protein 
 
 
 The results show Trx-MUC1 fusion protein is soluble in all detergents tested. This 
is great news, since options are available for future NMR studies.  
 Since Urea can be buffer exchanged to any detergent fairly easily, and 8M urea 
doesn’t affect (to too much of an extent) Ni affinity or size exclusion columns at that 
concentration, the buffer of choice for purification was a urea buffer. After expressing 
Trx-MUC1 fusion protein, the sample was dissolved in 20 mL of buffer containing 
50mM Tris-HCl, 8M urea, 200 mM NaCl, 10 mM 2-mercaptoethanol, and 2mM EDTA. 
The cells were lysed via French press at 1100 psi, and re-centrifuged for 30 minutes at 
18000 rpm at 4º C. The supernatant was collected and introduced into the Atka start 
FPLC containing a 10 mL Ni affinity column. The flow rate was set to 3mL/min. After 
washing the column with 10 CV’s of loading buffer, buffer B (containing 250mM 
imidazole) was introduced at a gradient. The elution fractions were collected in 5mL 
intervals, and associated UV peaks were run on an SDS-PAGE gel to find the fusion 
plasmid. The gel results are shown in figure 2.12 below. Note: Since 8M urea is too 
strong for SDS gels, the samples are diluted 4X. This is why the bands seem faint.  
 The results showed there was effective separation. The fractions showing 
presence of Trx-MUC1 were collected, buffer exchanged back to the initial suspending 
buffer (basically removing the imidazole), and concentrated to 5 milliliters. 300μL of 
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thrombin (5mg/mL stock) was added to cleave the thioredoxin, and incubated at 37ºC for 




Figure 2.12 SDS-PAGE Gel of Ni Column Fractions Containing Trx-MUC1 
 
 
 After thrombin cleavage, the sample was injected back into the FPLC with a 120 
mL HiLoad 16/60 superdex 75 prep grade size exclusion column attached. The column 
was equilibrated with the same urea buffer, and the flow rate was set to 0.5 mL/min. 5mL 




Figure 2.13 Size Exclusion Fractions Containing Trx-MUC1 
 
 
 The results are poor. The injected sample indicates some thioredoxin was cleaved, 
but not enough. The size exclusion column seemed to not effectively separate the proteins 
in the sample. Furthermore, the bands are quite faint, indicating the protein concentration 
is quite low. Overall, the protocol needs to be optimized to obtain a higher yield of 
MUC1-C+TM, and devise a way to obtain a more pure sample as well. On the positive 
side, it seems expression of mucin 1 was successful. For such a challenging protein, 









DISCUSSION AND FUTURE WORK 
 
1.1 Histone H4 Tail 
 The purification of Histone H4 Tail was a success thanks to the addition of 
thioredoxin and a His-tag to the protein. The protocol was optimized to produce a 
large enough protein sample for NMR spectroscopy. NMR studies using existing and 
novel NMR pulse sequences were –and still are being- conducted in Dr. Skrynnikov’s 
lab on the H4 tail. Future work on the histone H4 tail is being followed through by 
fellow colleague, Adam Groves. 
 
 
1.2 Mucin 1 
 After much work, mucin 1 -a hydrophobic and disordered protein- was able to be 
expressed in a cell culture with the help of the fusion protein thioredoxin. The fusion 
protein allowed mucin 1 to be so soluble that even the most gentle detergent was able 
to suspend it in solution. Unfortunately, thrombin conditions and column purification 
have yet to be optimized, and therefore, a sample concentrated enough for NMR 
analysis has yet to be made.  
 The future work for this protein would first require optimizing thrombin 
conditions. Once accomplished, focus would need to be made on column purification, 
and ensuring effective separation is made on the sample. Once purification conditions 
are optimal, the sample can be buffer exchanged to either DPC or DDM for NMR 
analysis. Once mucin 1 is characterized via NMR in a detergent micelle, it can be 
buffer exchanged to a nanodisc (see section 1.3.2 for more information). These 
nanodiscs should mimic a cellular environment well enough that mucin 1 should fold 
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and behave as if it were in its natural environment. Once characterized in a nanodisc, 




1.3 Final Remarks 
 This research illuminates the versatility of protein expression via bacterial growth. 
Despite many obstacles, many eukaryotic proteins can be expressed in bacterial cells, and 
purified with ease for characterization. These methods are effective enough to produce a 
yield high enough for NMR studies. This recent methodology available to the scientific 
community has made protein NMR analysis more viable, and far more controlled than 
before. It has been a pleasure learning these methods, and building skills for future work 
in the field of protein NMR analysis. I hope this research helps readers with their own 
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